558.94
-3.262(-0.58%)
Currency In CHF
Address
Muenchensteinerstrasse 38
Basel, 4002
Switzerland
Phone
41 61 316 81 11
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
17995
First IPO Date
March 07, 2006
| Name | Title | Pay | Year Born |
| Wolfgang Wienand | Chief Executive Officer | 0 | 1972 |
| Jason Berndt | Executive Vice President & Head of Group Operations | 0 | N/A |
| Matthias Hofmann | Head of Corporate Environment, Health, Safety & Global Sustainability | 0 | N/A |
| Andreas Bohrer | Chief Legal & Corporate Affairs Officer | 0 | N/A |
| Daniel Buchta | Head of Investor Relations | 0 | N/A |
| Philippe Deecke | Chief Financial Officer | 0 | N/A |
| Jennifer Clancy | Senior Director of Global Marketing | 0 | N/A |
| Kim Harrelson | Head of Ethics & Compliance, ERM and Corporate Responsibility | 0 | N/A |
| Nicoleta Baumgartner | Chief Human Resources Officer | 0 | 1971 |
| Victoria Morgan | Head of External Communications | 0 | N/A |
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.